Showing results (91-100 of 117) with videos related to
Sort By:
Pageof 12
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 4, 2001
Recommendations on health-related quality of life research to support labeling and promotional claims in the United StatesD A Revicki, D Osoba, D Fairclough, et al.The Journal of Clinical Psychiatry|February 1, 1997
Cost-effectiveness of newer antidepressants compared with tricyclic antidepressants in managed care settingsD A Revicki, R E Brown, M B Keller, et al.Journal of Patient-Reported Outcomes|May 15, 2018
The content validity of the PSS in patients with plaque psoriasisA M Rentz, A M Skalicky, K Burslem, et al.Alimentary Pharmacology & Therapeutics|July 10, 2003
Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom IndexD A Revicki, A M Rentz, D Dubois, et al.Alimentary Pharmacology & Therapeutics|June 30, 2009
Development and content validity of a gastroparesis cardinal symptom index daily diaryD A Revicki, M Camilleri, B Kuo, et al.AIDS Care|September 24, 2004
Measuring validity of self-reported symptoms among people with HIVA W Wu, N B Dave, M Diener-West, et al.JAMA|June 26, 1996
Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressantsG E Simon, M VonKorff, J H Heiligenstein, et al.Pharmacoeconomics|February 7, 1994
Cost utility of maintenance treatment of recurrent depression with sertraline versus episodic treatment with dothiepinE J Hatziandreu, R E Brown, D A Revicki, et al.Pharmacoeconomics|November 4, 1995
Modelling the cost effectiveness of antidepressant treatment in primary careD A Revicki, R E Brown, W Palmer, et al.Pharmacoeconomics|December 8, 1996
Acute medical costs of fluoxetine versus tricyclic antidepressants. A prospective multicentre study of antidepressant drug overdosesD A Revicki, C S Palmer, S D Phillips, et al.Pageof 12